Trigeminal Neuralgia Treatment Includes Acupuncture As It Is Found To Reduce The Intensity Of Headaches And Increase A Patient's Quality Of Sleep

Trigeminal Neuralgia Treatment
Trigeminal Neuralgia Treatment

Trigeminal neuralgia (TN) has various treatment options such as medications, surgical procedures and even acupuncture. Doctors will recommend a right course of treatment.

The most common medical Trigeminal Neuralgia Treatment is anti-convulsant medication, such as carbamazepine (Tegretol), phenytoin (Dilantin) and gabapentin (Neurontin). These medicines can provide significant pain relief in many patients with the condition. These medicines have some side effects, such as dizziness, rash, and liver damage, can occur.

As older individuals are more likely to develop the condition, an increasing geriatric population is anticipated to fuel growth in the Trigeminal Neuralgia Treatment Market globally.

Acupuncture can provide significant pain reduction in some patients with TN, especially those who do not respond to other treatments. Acupuncture also may improve quality of life for some people with TN, and a recent study found that it can reduce anxiety in TN patients.

If TN is not helped by medications, then the doctor may suggest surgery to remove or relocate blood vessels that are compressing the trigeminal nerve. The procedure is known as microvascular decompression, or MVD. This operation has a good long-term success rate and is less likely to cause other problems, such as hearing loss or facial numbness, than other types of surgical procedures for Trigeminal Neuralgia Treatment.

MVD is done in an outpatient setting with local anesthesia. It involves making a small incision behind the ear, drilling a small hole in the skull and moving away any blood vessels that are compressing the trigeminal root. Then, the surgeon inserts a padding made of Teflon felt into the space.

Doctors will perform a neurological examination to determine the location and triggers of TN-related pain. These tests help the doctor to diagnose TN, which is most often caused by the trigeminal nerve becoming compressed or pinched.

Scar Treatment is used to cure burn scars, hence throughout the course of the forecast period, an increase in burn injuries is anticipated to fuel market expansion.

Medications and injections that block the trigeminal nerve may help provide some pain relief for TN. Doctors may use a steroid medication or other agent to make an injection at different parts of the nerve.

Injections of onabotulinumtoxinA, or Botox, into the trigeminal nerve may decrease symptoms in some patients with TN who do not respond to other treatment. However, more research is needed to evaluate this method.

Along with medication and surgery, acupuncture has been shown to improve a patient's overall health and quality of life with Trigeminal Neuralgia Treatment. A randomized, controlled study found that accupuncture was as effective in controlling trigeminal neuralgia as standard care, and the treatment did not cause serious side effects or other complications. The Food and Drug Administration granted Fast Track designation to basimglurant (NOE-101) in October 2022. The drug used for managing pain associated due to trigeminal neuralgia.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more